ALPS Medical Breakthroughs ETF
SBIO
27 hedge funds and large institutions have $13.2M invested in ALPS Medical Breakthroughs ETF in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
27% more call options, than puts
Call options by funds: $849K | Put options by funds: $668K
17% more funds holding
Funds holding: 23 → 27 (+4)
4.29% less ownership
Funds ownership: 14.55% → 10.26% (-4.3%)
5% less capital invested
Capital invested by funds: $13.9M → $13.2M (-$745K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.44M |
| 2 |
Goldman Sachs
New York
|
+$1.2M |
| 3 |
Jane Street
New York
|
+$305K |
| 4 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
+$236K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.26M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.18M |
| 3 |
LPL Financial
San Diego,
California
|
-$834K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$324K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$133K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
26
Glenmede Trust
Philadelphia,
Pennsylvania
| $4K | – | – | – |
|
|
TCM
27
Tradewinds Capital Management
Bellingham,
Washington
| $2K | +$2.38K | +100 | New |
|
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.18M | -49,802 | Closed |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$324K | -14,800 | Closed |
|
|
AIG
30
American International Group
New York
| – | -$52K | -2,388 | Closed |
|
SBIO Hedge Fund Activity: Q2 2016 in Review
27 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2016, worth a combined $13.2M — down 5.4% from $13.9M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SBIO positions and 3 closed out — a net gain of 4 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.44M. The largest seller was Morgan Stanley, cutting an estimated $2.26M.
- 27 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2016, up from 23 in Q1 2016.
- Funds reported $13.2M of ALPS Medical Breakthroughs ETF stock for Q2 2016, down 5.4% quarter-over-quarter.
- 7 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2016 and 3 closed out, a net change of +4 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q2 2016 was Virtu Financial, an estimated $1.44M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q2 2016 was Morgan Stanley, an estimated $2.26M sold.
Based on aggregated 13F filings for Q2 2016.